
CL · NYSE
Reports Oct 30, 2026.
Consensus is $0.92 EPS for Sep 2026 across 9 estimates, ranging $0.89 to $0.94.
Colgate-Palmolive’s second quarter was an adjusted earnings beat with improving underlying margins, although reported earnings remained distorted by restructuring charges. Base Business EPS of $0.99 exceeded the $0.95 consensus by 4.21% and rose 8% from $0.92 a year ago. Net sales increased 4.9% to $5.361 billion from $5.110 billion, and organic sales grew 2.4%. Sequentially, sales increased from $5.32 billion in the first quarter, operating income rose to $1.016 billion from $964 million, net income increased to $693 million from $646 million, and GAAP diluted EPS improved to $0.86 from $0.80.
The print was defined by a broad but uneven recovery in the portfolio. Gross margin rose 140 basis points to 61.5% as cost savings and pricing more than offset raw-material and packaging inflation, lifting Base Business operating margin to 21.4%. Growth was strongest in Latin America and Asia Pacific, while North America remained weak and Hill’s faced volume pressure. At the same time, advertising rose 15% to $777 million, supporting future brand investment but contributing to higher selling expenses. The $129 million quarterly productivity-program charge drove GAAP operating profit down 6% to $1.016 billion. Management held sales guidance, raised adjusted EPS growth expectations, and now expects roughly flat full-year gross margins.
The quarter’s earnings quality was stronger than the GAAP figures suggest. Base Business operating profit rose 5% to $1.145 billion from $1.089 billion, and Base Business EPS increased 8% to $0.99 from $0.92. GAAP operating profit fell 6% to $1.016 billion because the productivity program added $129 million of pre-tax charges, compared with $9 million of acquisition-related costs in the year-ago quarter. Gross margin expansion was the central offset: the 61.5% rate benefited from 280 basis points of funding-the-growth savings and 60 basis points of pricing, partly offset by 220 basis points of higher raw and packaging costs.
Colgate’s underlying sales momentum was concentrated outside North America. Organic sales grew in four of five divisions, with volume improving sequentially for the third consecutive quarter. Latin America and Asia Pacific combined growth with positive volume, while North America’s decline reflected weaker U.S. Oral Care and Personal Care demand.
Hill’s delivered reported growth but a softer underlying volume profile. Sales increased 3.4% to $1.195 billion, driven by 3.9% pricing and 0.6% foreign exchange, while volume declined 1.2% on a reported basis and 1.8% organically. The Prime100 acquisition contributed 0.6% to reported volume. Organic growth of 2.1% included a 200-basis-point headwind from lower private-label pet food sales, although therapeutic and wellness categories grew.
Management is funding brand and capability investment while restructuring the organization. Advertising rose $99 million, or 15%, to $777 million and increased to 14.5% of sales from 13.3%. The company said investment would remain strong in the second half as it emphasizes premium, science-led innovation and omnichannel demand generation.
Cash generation improved despite continued investment and shareholder returns. Six-month operating cash flow reached $1.742 billion, up from $1.484 billion, while capital expenditures increased to $266 million from $232 million. Free cash flow before dividends rose to $1.476 billion from $1.252 billion.